Profile of immunological biomarkers in Behcet's syndrome: a large-scale single-center real-world study
- PMID: 39196452
- PMCID: PMC11358242
- DOI: 10.1007/s10238-024-01462-5
Profile of immunological biomarkers in Behcet's syndrome: a large-scale single-center real-world study
Abstract
Behcet's syndrome (BS) is a vasculitis characterized by immune dysregulation. Biomarkers are valuable for assessing clinically atypical pathogenesis. We aimed to investigate the distribution of different biomarkers and their effects on the clinical features of patients with BS in a large-scale, real-world study. This is a retrospective, single-center study. In total, 502 patients diagnosed with BS were enrolled in this study. We analyzed the clinical features of this cohort and divided patients' symptoms into six categories, including mucocutaneous, articular, neurological, gastrointestinal, vascular, and ocular involvements. HLA-B51 cells, autoantibodies, and subsets of immune cells from the patients were tested. Pearson's correlation, Wilcoxon rank sum test and multivariate logistic regression were used for data analysis. Various autoantibodies were detected in the serum of 40.8% of patients with BS. The positivity rate of anti-endothelial cell antibodies (AECA) was the highest among autoantibodies and was found in 23.5% (118/502) of patients with BS. The positivity rate of HLA-B51 in patients with BS was 27.1%. Tumor necrosis factor (TNF)-α, IL-2, and IL-4 producing CD4+ T cells were positively correlated with the gastrointestinal BS. Increased IL-4+CD4+ T cell was a risk factor for gastrointestinal BS (P = 0.006, Overall rate [OR] = 2.491, 95% Confidence interval [CI]: [1.317, 5.100]). Various autoantibodies can be detected in patients with BS. HLA-B51 and AECA are the most common biomarkers. Increased IL-4+ CD4+ T cell was a risk factor for gastrointestinal involvement in BS.
Keywords: Behcet’s syndrome; Biomarkers; Clinical features; Gastrointestinal involvement.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
[The distribution of biomarkers for Behcet syndrome and their clinical relevance in real-world studies].Zhonghua Yu Fang Yi Xue Za Zhi. 2024 Sep 6;58(9):1341-1347. doi: 10.3760/cma.j.cn112150-20231110-00332. Zhonghua Yu Fang Yi Xue Za Zhi. 2024. PMID: 39290014 Chinese.
-
Transcriptome analysis of immune cells from Behçet's syndrome patients: the importance of IL-17-producing cells and antigen-presenting cells in the pathogenesis of Behçet's syndrome.Arthritis Res Ther. 2022 Aug 8;24(1):186. doi: 10.1186/s13075-022-02867-x. Arthritis Res Ther. 2022. PMID: 35941595 Free PMC article.
-
When it looks like Behçet's syndrome but is something else: differential diagnosis of Behçet's syndrome: a two-centre retrospective analysis.Rheumatology (Oxford). 2023 Nov 2;62(11):3654-3661. doi: 10.1093/rheumatology/kead101. Rheumatology (Oxford). 2023. PMID: 36864623
-
Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies.Rheumatology (Oxford). 2012 May;51(5):887-900. doi: 10.1093/rheumatology/ker428. Epub 2012 Jan 11. Rheumatology (Oxford). 2012. PMID: 22240504 Review.
-
Behçet's syndrome: a critical digest of the 2014-2015 literature.Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S3-14. Epub 2015 Oct 19. Clin Exp Rheumatol. 2015. PMID: 26487500 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials